Gurinder Singh Kalra Retires As Independent Director Of Dr. Lal PathLabs

Dr. Lal PathLabs Limited announced that Gurinder Singh Kalra has ceased to be an Independent Director of the company effective July 26, 2026, following the completion of his tenure.

Kalra has served as Chief Financial Officer (CFO) of a NASDAQ-listed biotechnology company, where he managed the company’s SPAC merger and de-SPAC process. He has worked with global investment banks including Credit Suisse First Boston, Morgan Stanley and Bear Stearns, advising technology companies on capital raising and mergers and acquisitions (M&A). He brings expertise in public and private fundraising, investor relations, and financial strategy, along with an understanding of technology processes and implementation. He holds an MBA from Harvard University and bachelor’s degrees in Science and Arts from Brown University.

a

Magazine made for you.